Merck Sharp & Dohme B.V. (primary and secondary packaging, quality control, batch release authorization)

The drug is used as add-on treatment for bronchial asthma (if it is not sufficiently controlled by other agents), for the prevention of exercise-induced asthma, and to relieve the symptoms of seasonal and perennial allergic rhinitis.

Dosage form: tablets, film-coated

ATC: R03DC03